Myopia Control Options Compared: Ortho-K, MiSight, Atropine and Glasses
Once you decide to slow your child’s nearsightedness, the next question is which method — and the honest answer is that there is no universal winner, but there is a structured way to choose. This page compares the real options on the things that actually decide it: what each one demands day to day, how each is approved, who it suits, and what it will not do.
What every method is trying to do — and what none of them do
Myopia progresses because the eyeball grows slightly too long. Light then focuses in front of the retina instead of on it, and each increase in length means a stronger prescription.
Every method here aims at the same thing: slowing that growth, so your child reaches adulthood with a lower final prescription than they otherwise would. That matters beyond thick glasses — higher myopia carries a higher lifetime risk of retinal problems, and the prescription your child stops at is the one they live with.
None of these methods reverses myopia. Nothing here shortens an eye that has already grown. Any product or programme promising to reduce an existing prescription is making a claim the evidence does not support.
The four real options
Orthokeratology (Ortho-K)
Rigid lenses worn overnight gently reshape the cornea, so your child wakes up, takes them out, and sees clearly all day with nothing on their eyes.
Suits: active children, swimmers, contact sports, anyone who would struggle with daytime lenses or dislikes glasses. Also the child who simply will not tolerate wearing something all day.
Demands: nightly wear, disciplined handling and cleaning, and regular follow-up. The effect is temporary — miss enough nights and vision blurs again.
Approval: Ortho-K lenses are FDA-approved for temporarily correcting nearsightedness. Using them specifically to slow progression is a recognised off-label use. Widely practised, well described, but worth stating plainly.
Start with what is Ortho-K and are Ortho-K lenses safe.
MiSight and other soft myopia-control lenses
Soft daily-disposable lenses worn during the day, designed with treatment zones that sit alongside the child’s distance correction.
Suits: children who are comfortable with daytime lenses and want the simplest possible care routine. Nothing to clean, nothing to store.
Demands: daily insertion and removal, and enough wearing hours each day to do their job. A lens in the packet does nothing.
Approval: MiSight was the first contact lens to receive FDA approval for slowing myopia progression in children — a genuine distinction, since most myopia-control treatments are used off-label.
See myopia control contact lenses and CooperVision MiSight lenses.
Low-dose atropine drops
One drop at bedtime. No lens handling at all.
Suits: younger children, children not ready for contact lenses, families who want the lowest daily burden — and children who keep progressing on a lens treatment and need something added.
Demands: remembering the drop every night, and a prescription refilled from a compounding pharmacy.
Approval: low-dose atropine is not FDA-approved for myopia control in the United States. It is prescribed off-label and compounded, because commercial atropine comes at much higher concentrations. Concentration matters a great deal here — the weakest dilutions performed poorly in several trials, and stronger low doses are generally used now.
See myopia control drops and atropine drops.
Myopia-control spectacle lenses
Purpose-built spectacle lenses with treatment zones surrounding a clear centre. Not the same thing as ordinary glasses, and not the same thing as progressive lenses.
Suits: young children, families who prefer glasses, and any child for whom lenses of any kind are not realistic yet.
Demands: wearing them, essentially all waking hours. Availability varies, so ask what can actually be dispensed for your child.
See glasses that slow down myopia.
Comparing them on what actually decides it
| Worn | Daily burden | Visible correction in the day | Approval status | |
|---|---|---|---|---|
| Ortho-K | Overnight | Handling and cleaning nightly | None | Approved for correction; myopia control off-label |
| MiSight | Daytime | Insert and discard daily | Contact lenses | FDA-approved for myopia control |
| Low-dose atropine | Bedtime drop | Lowest | Glasses or lenses still needed | Off-label, compounded |
| Myopia-control glasses | All day | Lowest handling | Glasses | Varies — ask what is available |
On effectiveness, most clinical summaries put the same group at the top: 0.05% atropine, MiSight, Ortho-K and purpose-built myopia-control spectacles. Lower atropine concentrations and some multifocal designs sit below that. Standard single-vision glasses and contact lenses sit at the bottom, because they do nothing to slow progression at all — they correct vision and that is all.
Our own summary of how these tiers compare is on the myopia control in Michigan guide, with the caveat that belongs on every version of this comparison: averages across studies are not predictions about your child.
What does not work
Worth saying clearly, because it is searched for constantly.
Eye exercises do not slow myopia. Focus-training routines, “vision improvement” programmes and exercises sold to reduce nearsightedness do not slow progression and do not reverse it. Myopia is eye length. No exercise changes eye length.
This is different from vision therapy, which is a legitimate treatment for genuine binocular vision problems such as convergence insufficiency — a real condition, treated for real reasons, that has nothing to do with slowing myopia.
Standard glasses and standard contact lenses do not slow myopia. They correct it. A child in ordinary single-vision correction is not being treated for progression, and many parents reasonably assume otherwise.
Under-correcting deliberately does not help. It was once thought it might. It does not, and it leaves a child seeing worse in the meantime.
How the decision actually gets made
The part most comparison pages leave out: the choice should follow measurement, not preference.
Axial length — the actual front-to-back length of the eye — is the measurement that matters, because it is what is changing. Prescription alone is a blunt proxy and moves in steps. Tracking axial length over time shows whether a treatment is working while there is still time to change course.
That reframes the question. It is less “which option is best” and more “start the option your child will realistically use every day, measure, and adjust.” The treatment a child actually complies with beats the theoretically stronger one they abandon in a month.
Practical factors carry real weight here: how your child feels about lenses, who supervises the routine, whether mornings are already chaotic, and how far you are from the office for follow-ups.
Combining approaches
These are not always either/or. Atropine alongside a lens-based treatment is the common pairing, usually for a child who keeps progressing on one treatment alone. That decision follows the measurements rather than being tried speculatively.
If your child’s prescription keeps climbing, see why is my child’s prescription getting worse and the parent guide at myopia control for kids.
Time outdoors
Independent of treatment, more time outdoors is associated with slower myopia progression in children. It is not a substitute for treatment in a child who is already progressing, and it costs nothing to encourage. See outdoor time and myopia.
Ready to choose the right myopia control plan?
Dr. Shira Kresch, OD, MS, FAAO offers children’s myopia control at Michigan Contact Lens in Southfield, serving families across Metro Detroit. Your child’s initial consultation is complimentary, and you will leave knowing what is actually changing in their eyes — not just that the prescription went up again.
Frequently Asked Questions
- Do eye exercises slow myopia?
No. Eye exercises, focus training and vision-therapy routines sold for nearsightedness do not slow myopia progression and do not reverse it. Myopia is a structural change — the eyeball grows too long — and no exercise shortens an eyeball. Vision therapy is a legitimate treatment for genuine binocular vision problems such as convergence insufficiency, which is a different condition entirely. If a program promises to reduce your child’s prescription through exercises, that promise is not supported.
- Which myopia control method is most effective?
The higher-efficacy group is broadly the same in most clinical summaries — 0.05% atropine, MiSight daily lenses, orthokeratology and purpose-built myopia-control spectacle lenses. Below that sit lower atropine concentrations and some multifocal designs, and standard single-vision glasses and contact lenses do nothing to slow progression at all. But “most effective on average” and “best for your child” are different questions, and the second one depends on age, prescription, eye health and whether the child will actually use the treatment every day.
- Is Ortho-K approved for myopia control?
Orthokeratology lenses are FDA-approved for temporarily correcting nearsightedness overnight. Using them to slow progression is a recognised off-label use — widely practised and well described in the literature, but not what the approval itself covers. That is worth knowing, and any practice fitting Ortho-K for myopia control should tell you plainly.
- Is low-dose atropine FDA-approved for myopia control?
Not in the United States. Low-dose atropine for myopia control is prescribed off-label and is prepared by a compounding pharmacy, since commercial atropine is sold at much higher concentrations. It is used widely and studied extensively, but the off-label and compounded status is something parents should hear up front rather than discover later.
- At what age should myopia control start?
Generally as soon as progression is documented, because the aim is to prevent prescription that has not happened yet. Myopia progresses fastest in younger children, so the window where treatment does the most good is early — which is also when parents are least likely to have been told the option exists. See when to start myopia control.
- Can myopia control be combined?
Yes, and it is fairly common. Atropine alongside a lens-based treatment is the usual combination, typically for a child who keeps progressing on one treatment alone. Combining is a clinical decision that follows measurement rather than something to try speculatively.
- Does myopia control reverse my child's nearsightedness?
No, and be cautious of anything claiming otherwise. Every method here slows how fast the prescription worsens. None of them shortens the eye or removes myopia that is already present. Ortho-K is the partial exception in appearance only — it temporarily reshapes the cornea so your child sees clearly without daytime correction, but the underlying eye length is unchanged and vision returns to baseline if lens wear stops.
Related reading
Will My Child Outgrow Nearsightedness?
Will a child outgrow nearsightedness? Usually not — but here's what really happens to myopia over time and what you can do to slow it down.
How Outdoor Time Protects Kids' Eyes From Myopia
Spending more time outdoors is one of the simplest, evidence-based ways to lower a child's risk of myopia. Here's how much helps and why it works.
Why Is My Child's Prescription Getting Worse Every Year?
Is it normal for a child's glasses prescription to keep getting stronger? Learn why childhood myopia progresses and what you can do to slow it down.
What Is High Myopia, And Why Is It Risky?
High myopia is more than a strong prescription — it raises the lifelong risk of serious eye conditions. Learn what it is, the risks, and why early control…
MiSight Contact Lenses Vs. Ortho-K: A Parent's Comparison
MiSight soft lenses or Ortho-K for your child's myopia? Compare how they're worn, comfort, candidacy, and which fits your child's lifestyle best.
Myopia Control For Kids: A Metro Detroit Parent's Guide
A Michigan parent's guide to myopia control for children — why nearsightedness is rising, why slowing it matters, and the treatment options available near…
Ready to see clearly again?
Michigan Contact Lens fits scleral and specialty lenses for keratoconus, irregular corneas, corneal transplants, and severe dry eye.